This post tries to detail how our three monthly injection regime was arrived at from the first study and the following three GP audits
Nausea occurred in approximately 24-33% of participants across all tirzepatide doses, but it was most common during dose escalation phases and typically resolved within two to three weeks of stabilizing at a new dose
Take note and inform your doctor of unusual reactions to the peptide
Their phase 3 study (Curr Neuropharmacol, 2016) demonstrated that injectable BPC-157 at 10 mcg/kg body weight accelerated healing in various tissue types, including gastric ulcers, tendon injuries, and bone fractures in animal models
UPS and FedEx by request), which means youre likely to be near a convenient drop-off
While not as effective as a commercial filter, it will remove sediment and some toxins